https://cxcrsignals.com/index.....php/massive-temporal
An assessment of the clinical applicability of freehand interstitial brachytherapy via intraoperative catheter implantation in the treatment of early breast cancer following breast-conserving surgery (BCS). Between January 2018 and December 2019, a phase II single-arm trial enrolled 44 individuals with early breast cancer following breast-conserving surgery (BCS). These patients met the following inclusion criteria: a maximum age of 45, an invasive carcinoma no larger than 3cm, or d
پسندیدن
اظهار نظر
اشتراک گذاری
